Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (331K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Castro JE, Griffiths HJ, Edwards DE. A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy. Br J Surg. 1971 Jul;58(7):485–489.[PubMed]
Castro JE, Griffiths HJ, Shackman R. Significance of signs and symptoms in benign prostatic hypertrophy. Br Med J. 1969 Jun 7;2(5657):598–601.[PMC free article][PubMed]
COOK EN. Diagnosis and treatment of benign prostatic hyperplasia. Postgrad Med. 1963 May;33:446–448.[PubMed]
Geller J, Fruchtman B, Meyer C, Newman H. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate. J Clin Endocrinol Metab. 1967 Apr;27(4):556–560.[PubMed]
Griffiths HJ, Castro J. An evaluation of the importance of residual urine. Br J Radiol. 1970 Jun;43(510):409–413.[PubMed]
HOLTGREWE HL, VALK WL. LATE RESULTS OF TRANSURETHRAL PROSTATECTOMY. J Urol. 1964 Jul;92:51–55.[PubMed]
JEEJEEBHOY H. Prostatectomy. An analysis of the factors contributing to mortality and morbidity after prostatectomy and a description of a personal technique. Br J Urol. 1961 Jun;33:178–192.[PubMed]
Watts HG. Prostatectomy: a review of 246 operations. N Z Med J. 1968 Feb;67(428):211–215.[PubMed]
Wolf H, Madsen PO. Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report. J Urol. 1968 Jun;99(6):780–785.[PubMed]
Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press